Technology
Scancell losses widen on expense of ongoing trials
Cancer and infectious disease immunotherapy developer Scancell reported an operating loss of £13. 3m in its final results on Friday, widening from £8. 8m year-on-year, which it put down to the expense of its three ongoing clinical trials.
Directa Plus inks supply deal with Colombian body armour maker
Graphene nanoplatelets specialist Directa Plus has concluded its first exclusive supply agreement for its printed graphene textile ‘Planar Thermal Circuit’ (PTC) in Latin America, it announced on Friday.
Iofina to build new iodine plant in Western Oklahoma
Iodine and specialty chemicals producer Iofina has executed all agreements with a new brine supply partner to construct its latest ‘IOsorb’ iodine plant, IO9, in Western Oklahoma, it announced on Friday.
Plant Health Care inks new deal with Portugal partner
Agricultural biologicals specialist Plant Health Care has signed an agreement for EDAF Unipessoal to become the exclusive distributor in Portugal for its proprietary ‘PREtec’-containing fertiliser, ‘PREzym’, for use in fruit, vegetable and cereals crop production, it announced on Friday.